Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience

Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2021-11, Vol.131 (11), p.2578-2585
Hauptverfasser: Lovin, Benjamin D., Hernandez, Mike, Elms, Hunter, Choi, Jonathan S., Lindquist, Nathan R., Moreno, Amy C., Nader, Marc‐Elie, Gidley, Paul W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2585
container_issue 11
container_start_page 2578
container_title The Laryngoscope
container_volume 131
creator Lovin, Benjamin D.
Hernandez, Mike
Elms, Hunter
Choi, Jonathan S.
Lindquist, Nathan R.
Moreno, Amy C.
Nader, Marc‐Elie
Gidley, Paul W.
description Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. Results TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. Conclusions TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. Level of Evidence 4 Laryngoscope, 131:2578–2585, 2021
doi_str_mv 10.1002/lary.29758
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9214913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2553818414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</originalsourceid><addsrcrecordid>eNp9kctKxDAUhoMoOl42PkHBjYjVXKeJC2EUbzAw4AV0FdL2VCOddExadXY-gs_ok5hxRNCFi3D4-b_8nAtCmwTvEYzpfm38dI-qTMgF1COCkZQrJRZRL5oslYLerqDVEB4xJhkTeBmtME5lJpXsodE1jCeNN3Vy1DhIRqGFqEobReGbYMNBMnAJkR9v71Mwfje5su6-higvXGht27URTU5eJ-AtuALW0VJl6gAb33UN3ZyeXB-fp8PR2cXxYJgWnAqZliITSpWEVlmZc6ZoJQTDQuXAikr2-0plDBgU0VcKG05Libkp-lVFc-AmZ2vocJ476fIxlAW4Ng6hJ96O4zZ0Y6z-7Tj7oO-bZ60o4YqwGLD9HeCbpw5Cq8c2FFDXxkHTBU1jQ5JITnhEt_6gj03nXRwvUhLHlxESqZ05Ndtb8FD9NEOwnt1Jz-6kv-4UYTKHX2wN039IPRxc3s3_fAJX95Z-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580258711</pqid></control><display><type>article</type><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</creator><creatorcontrib>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</creatorcontrib><description>Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. Results TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. Conclusions TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. Level of Evidence 4 Laryngoscope, 131:2578–2585, 2021</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1002/lary.29758</identifier><identifier>PMID: 34287898</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Diabetes ; Laryngoscopy ; osteoradionecrosis ; Patients ; radiation ; Radiation therapy ; Skin cancer ; Temporal bone</subject><ispartof>The Laryngoscope, 2021-11, Vol.131 (11), p.2578-2585</ispartof><rights>2021 The American Laryngological, Rhinological and Otological Society, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</citedby><cites>FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</cites><orcidid>0000-0002-5074-5460 ; 0000-0001-9015-4895 ; 0000-0003-3706-8781 ; 0000-0001-6762-6807 ; 0000-0001-8923-6527 ; 0000-0003-1509-8971 ; 0000-0003-2008-518X ; 0000-0001-9295-0174</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flary.29758$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flary.29758$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Lovin, Benjamin D.</creatorcontrib><creatorcontrib>Hernandez, Mike</creatorcontrib><creatorcontrib>Elms, Hunter</creatorcontrib><creatorcontrib>Choi, Jonathan S.</creatorcontrib><creatorcontrib>Lindquist, Nathan R.</creatorcontrib><creatorcontrib>Moreno, Amy C.</creatorcontrib><creatorcontrib>Nader, Marc‐Elie</creatorcontrib><creatorcontrib>Gidley, Paul W.</creatorcontrib><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><title>The Laryngoscope</title><description>Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. Results TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. Conclusions TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. Level of Evidence 4 Laryngoscope, 131:2578–2585, 2021</description><subject>Diabetes</subject><subject>Laryngoscopy</subject><subject>osteoradionecrosis</subject><subject>Patients</subject><subject>radiation</subject><subject>Radiation therapy</subject><subject>Skin cancer</subject><subject>Temporal bone</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kctKxDAUhoMoOl42PkHBjYjVXKeJC2EUbzAw4AV0FdL2VCOddExadXY-gs_ok5hxRNCFi3D4-b_8nAtCmwTvEYzpfm38dI-qTMgF1COCkZQrJRZRL5oslYLerqDVEB4xJhkTeBmtME5lJpXsodE1jCeNN3Vy1DhIRqGFqEobReGbYMNBMnAJkR9v71Mwfje5su6-higvXGht27URTU5eJ-AtuALW0VJl6gAb33UN3ZyeXB-fp8PR2cXxYJgWnAqZliITSpWEVlmZc6ZoJQTDQuXAikr2-0plDBgU0VcKG05Libkp-lVFc-AmZ2vocJ476fIxlAW4Ng6hJ96O4zZ0Y6z-7Tj7oO-bZ60o4YqwGLD9HeCbpw5Cq8c2FFDXxkHTBU1jQ5JITnhEt_6gj03nXRwvUhLHlxESqZ05Ndtb8FD9NEOwnt1Jz-6kv-4UYTKHX2wN039IPRxc3s3_fAJX95Z-</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Lovin, Benjamin D.</creator><creator>Hernandez, Mike</creator><creator>Elms, Hunter</creator><creator>Choi, Jonathan S.</creator><creator>Lindquist, Nathan R.</creator><creator>Moreno, Amy C.</creator><creator>Nader, Marc‐Elie</creator><creator>Gidley, Paul W.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5074-5460</orcidid><orcidid>https://orcid.org/0000-0001-9015-4895</orcidid><orcidid>https://orcid.org/0000-0003-3706-8781</orcidid><orcidid>https://orcid.org/0000-0001-6762-6807</orcidid><orcidid>https://orcid.org/0000-0001-8923-6527</orcidid><orcidid>https://orcid.org/0000-0003-1509-8971</orcidid><orcidid>https://orcid.org/0000-0003-2008-518X</orcidid><orcidid>https://orcid.org/0000-0001-9295-0174</orcidid></search><sort><creationdate>202111</creationdate><title>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</title><author>Lovin, Benjamin D. ; Hernandez, Mike ; Elms, Hunter ; Choi, Jonathan S. ; Lindquist, Nathan R. ; Moreno, Amy C. ; Nader, Marc‐Elie ; Gidley, Paul W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4258-d57599d12f7db4392f553059be3cf8669973e3ec2f7990a42d804ac6ff2be4ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Diabetes</topic><topic>Laryngoscopy</topic><topic>osteoradionecrosis</topic><topic>Patients</topic><topic>radiation</topic><topic>Radiation therapy</topic><topic>Skin cancer</topic><topic>Temporal bone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lovin, Benjamin D.</creatorcontrib><creatorcontrib>Hernandez, Mike</creatorcontrib><creatorcontrib>Elms, Hunter</creatorcontrib><creatorcontrib>Choi, Jonathan S.</creatorcontrib><creatorcontrib>Lindquist, Nathan R.</creatorcontrib><creatorcontrib>Moreno, Amy C.</creatorcontrib><creatorcontrib>Nader, Marc‐Elie</creatorcontrib><creatorcontrib>Gidley, Paul W.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lovin, Benjamin D.</au><au>Hernandez, Mike</au><au>Elms, Hunter</au><au>Choi, Jonathan S.</au><au>Lindquist, Nathan R.</au><au>Moreno, Amy C.</au><au>Nader, Marc‐Elie</au><au>Gidley, Paul W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience</atitle><jtitle>The Laryngoscope</jtitle><date>2021-11</date><risdate>2021</risdate><volume>131</volume><issue>11</issue><spage>2578</spage><epage>2585</epage><pages>2578-2585</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><abstract>Objectives/Hypothesis To report the largest single‐institution review of temporal bone osteoradionecrosis (TBORN), and characterize the disease's natural history, prognostic factors, management, and outcomes. Study Design Retrospective chart review. Methods Retrospective review was conducted to identify patients with TBORN. Pertinent data were extracted. Descriptive statistics were used to summarize patient, tumor, and treatment characteristics. Multivariable analyses were conducted to explore associations between these characteristics and time to TBORN diagnosis and risk of developing diffuse disease. Results TBORN was identified in 145 temporal bones from 128 patients. Mean age at diagnosis was 62 years, and mean time to diagnosis after radiotherapy was 10 years. Age greater than 50 years was associated with earlier diagnosis. According to the Ramsden criteria, 76% of TBs had localized and 24% had diffuse disease at initial diagnosis; 37% had diffuse disease at last follow‐up. On multivariable analysis, diabetes, three‐dimensional conformal radiotherapy (3D‐CRT), and periauricular skin malignancy were significant risk factors for developing diffuse disease. Localized disease was successfully managed with conservative measures, whereas surgery was often necessary for diffuse disease. When TBORN spread outside the mastoid or infratemporal fossa, conservative measures were always unsuccessful. Conclusions TBORN occurs earlier in older patients. While diffuse disease is less common than localized disease, it occurs more frequently in patients with diabetes, history of 3D‐CRT, and periauricular skin malignancies. Conservative management is appropriate for localized disease, while surgery is often necessary for diffuse disease. The prognostic factors identified helped propose a TBORN staging system and treatment guidelines which may improve patient risk stratification and disease management. Level of Evidence 4 Laryngoscope, 131:2578–2585, 2021</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34287898</pmid><doi>10.1002/lary.29758</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5074-5460</orcidid><orcidid>https://orcid.org/0000-0001-9015-4895</orcidid><orcidid>https://orcid.org/0000-0003-3706-8781</orcidid><orcidid>https://orcid.org/0000-0001-6762-6807</orcidid><orcidid>https://orcid.org/0000-0001-8923-6527</orcidid><orcidid>https://orcid.org/0000-0003-1509-8971</orcidid><orcidid>https://orcid.org/0000-0003-2008-518X</orcidid><orcidid>https://orcid.org/0000-0001-9295-0174</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0023-852X
ispartof The Laryngoscope, 2021-11, Vol.131 (11), p.2578-2585
issn 0023-852X
1531-4995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9214913
source Wiley Online Library Journals Frontfile Complete
subjects Diabetes
Laryngoscopy
osteoradionecrosis
Patients
radiation
Radiation therapy
Skin cancer
Temporal bone
title Temporal Bone Osteoradionecrosis: An 18‐year, Single‐Institution Experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A10%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20Bone%20Osteoradionecrosis:%20An%2018%E2%80%90year,%20Single%E2%80%90Institution%20Experience&rft.jtitle=The%20Laryngoscope&rft.au=Lovin,%20Benjamin%20D.&rft.date=2021-11&rft.volume=131&rft.issue=11&rft.spage=2578&rft.epage=2585&rft.pages=2578-2585&rft.issn=0023-852X&rft.eissn=1531-4995&rft_id=info:doi/10.1002/lary.29758&rft_dat=%3Cproquest_pubme%3E2553818414%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2580258711&rft_id=info:pmid/34287898&rfr_iscdi=true